Obstructive sleep apnea syndrome
Therapeutic area
Pulmonology
Rare disease
No
- Definition
- Cessation of air flow during sleep due to upper airway obstruction.
- Genetic basis
- Yes
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Obstructive sleep apnea syndrome
- Therapeutic area
- Pulmonology
- obstructive sleep apnea syndrome
- obstructive sleep apnea
- obstructive sleep apnea syndrome
- Apneas, obstructive sleep
- OSAHS
- apnea, obstructive sleep
- obstructive sleep Apneas
- sleep Apneas, obstructive
- sleep apnea hypopnea syndrome
- sleep apnea syndrome, obstructive
- syndrome, obstructive sleep apnea
- syndrome, sleep apnea, obstructive
- syndrome, upper airway resistance, sleep apnea
- upper airway resistance sleep apnea syndrome
- Disease mechanisms
- Syndromic
- All therapeutic areas
- Pulmonology
- Severity
- Mild
- MONDO ID
- MONDO:0007147
- Parent condition
- MONDO:0002254
Related records
Broader conditions (9)
- Disease
- Disease by body system or component
- Disease by developmental or physiological process
- Human disease
- Respiratory system disorder
- Sleep apnea syndrome
- Sleep disorder
- Sleep-wake disorder
- Syndromic disease
Narrower conditions (1)
- Complex sleep apnea
Trials (2,140)
- "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"
- "Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"
- "Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
- "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
- 12-week Tele-exercise Program in Patients With OSA
- 19/5000 (SYNAPSOT21) Predictive Factors of Sleep Apnea Syndrome in Down Syndrome
- 3D Printer Modified CPAP Mask for Obstructive Sleep Apnea
- 3D Volumetric Changes in the Upper Airway After MMA in OSAS Patients and the Implication on QOL: A Prospective Registry
- 3D-Printed CPAP Masks for Children With Obstructive Sleep Apnea
- A 2 Week, Crossover Trial of Dietary Nitrate in Obstructive Sleep Apnoea Syndrome (OSAS).
- A Brief Lifestyle Modification Programme in Overweight Subjects With Obstructive Sleep Apnoea - Needs Assessment
- A Cardiosleep Research Program on Obstructive Sleep Apnea, Blood Pressure Control and Maladaptive Myocardial Remodeling
- A Cohort Study on Increasing Blood Pressure Benefits in Sleep Apnea Patients After CPAP Treatment
- A Community Study of the Risk for Obstructive Sleep Apnea and Respiratory Inflammation in an Adult Chinese Population
- A Comparative Effectiveness Study of Positive Airway Pressure (PAP) Therapy, Dental Device, and Atomoxetine-Oxybutynin for Treatment of Obstructive Sleep Apnea in Adults
- A Comparison of CPAP With and Without Humidification: A Pilot Study
- A Comparison of Surgical Outcome Following Drug-induced Sleep Endoscopic Diagnosis Using Propofol or Dexmedetomidine for Sedation : A Prospective Randomized Trial
- A Cross-sectional Study Examining Adipose Tissue in Obstructive Sleep Apnea
- A Cross-sectional Study of the Occurrence and Effect of Obstructive Sleep Apnea in Subjects With Resistant Hypertension
- A Development Study to Evaluate a Full-Face Mask for the Treatment of Obstructive Sleep Apnea
Approved drugs (4)
- Armodafinil
- Modafinil
- Pitolisant hydrochloride
- Solriamfetol hydrochloride
Drugs in development (52)
- Acetazolamide Phase 2
- Aroxybutynin Phase 3
- Atomoxetine Phase 2
- Atomoxetine hydrochloride Phase 2
- Atorvastatin Phase 2
- Budesonide Phase 3
- Calcifediol Phase 2
- Dalfampridine Phase 2
- Danavorexton Phase 1
- Daridorexant Phase 1
- Desipramine Phase 2
- Dexamethasone Phase 3
- Dexmedetomidine Phase 3
- Dimethyl fumarate Phase 2
- Dronabinol Phase 2
- Eszopiclone Phase 2
- Fentanyl Phase 3
- Gefapixant Phase 1
- Ibuprofen Phase 3
- Lemborexant Phase 1
Other linked drugs (6)
- Allopurinol
- Ketorolac
- Lidocaine hydrochloride
- Nalbuphine
- Retinol
- Vitamin E